Monogram Orthopaedics, Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Monogram Orthopaedics, Inc. (MGRM) develops advanced orthopedic technologies focused on personalized joint replacement solutions, including patient-specific 3D-printed implants for hip and knee arthroplasty; semi-autonomous AI-guided surgical robots such as the mBôs system for total knee arthroplasty; proprietary predictive analytics software for preoperative planning; and related navigation consumables and tissue ablation tools. Founded in 2016 and headquartered in Austin, Texas, the company targets orthopedic surgeons and healthcare institutions in the United States with its mass-customization platform combining robotic precision and additive manufacturing to improve surgical outcomes, stability, and recovery times. In October 2025, Monogram Orthopaedics was acquired by Zimmer Biomet Holdings, Inc. for approximately $177 million in a deal that integrates its autonomous robotics into Zimmer Biomet's ROSA platform, delists MGRM shares from NASDAQ, and positions the technologies for enhanced commercialization starting in 2027.
Monogram Technologies Inc. (MGRM) Shareholder/Analyst Call Prepared Remarks Transcript
Zimmer Biomet Announces Second Quarter 2025 Financial Results
Monogram Technologies Announces World's First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery
MONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRM
MGRM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Monogram Technologies to Zimmer Biomet
Shareholder Alert: The Ademi Firm Investigates Whether Monogram Technologies Inc. is Obtaining a Fair Price for its Public Shareholders
MGRM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Monogram Technologies Inc. Is Fair to Shareholders
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
Monogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred Stock
Monogram Technologies Inc. (MGRM) Q1 2025 Earnings Call Transcript
Monogram Technologies Reports First Quarter 2025 Financial Results
Monogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time
CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India
Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India
Monogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder Community
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA System
Monogram Technologies Inc. (MGRM) Q4 2024 Earnings Call Transcript
CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results
Monogram Technologies Reports Full Year 2024 Financial Results